Hypertension is believed to be the single greatest factor influencing the development of heart failure, particularly heart failure with preserved ejection fraction, also known as diastolic heart ...
TEWKSBURY, Mass.--(BUSINESS WIRE)--DC Devices, Inc., a medical device company pioneering first-in-class structural heart devices, has closed a $34 million Series D financing round. Accelmed led the ...
Diastolic dysfunction increasingly is recognized as an important cause of congestive heart failure (CHF). In this study, Mayo Clinic researchers surveyed a random sample of 2042 adults (age, 45 or ...
Heart failure with preserved ejection fraction (HFpEF) has limited treatment options and remains a medical challenge. HFpEF is characterized by diastolic dysfunction with a normal ejection fraction.
Cardiomyopathy is the leading cause of mortality in patients with DMD. Compared with their healthy counterparts, patients with DMD — including those with preserved left ventricular ejection fraction ...
TCT 760: Valve In Valve Transcatheter Versus Redo Surgical Replacement of a Failing Bioprosthetic Aortic Valve: An Updated Meta-Analysis of Echocardiographic and Long-Term Outcomes Receive the the ...
Heart failure can happen two ways: The heart fails to pump blood, or the heart fails to fill with blood. For decades, cardiologists blurred the two, trying drugs that treat systolic heart failure (not ...
For the first time in the U.S., a clinical trial is underway that's evaluating a device designed to treat diastolic heart failure. The first patient enrolled in the randomized, blinded study is being ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results